Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Published on by Cell Biologist

Prof. Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Prof. Dukagjin Blakaj, The Ohio State University, United States

Dr. Dukagjin M. Blakaj, MD, PhD, is a distinguished physician-scientist and academic leader in radiation oncology, specializing in proton therapy. Currently serving as the Vice Chair of Clinical Operations and holding the prestigious Drs. Malati and Ganesh Potdar Endowed Professorship at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital, he brings visionary leadership in patient-centered oncology care. With dual degrees in medicine and biochemistry, Dr. Blakaj integrates clinical expertise with advanced translational research. He is renowned for developing innovative radiotherapy protocols, advancing artificial intelligence applications in oncology, and mentoring future clinician-scientists. His work significantly influences treatment outcomes for head and neck cancers, including HPV-related oropharyngeal cancer, and is published in top-tier journals. A respected thought leader and collaborative partner, Dr. Blakaj embodies excellence in academic medicine, multidisciplinary team leadership, and compassionate patient care.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Blakaj’s educational path is both extensive and interdisciplinary. He earned his MD, PhD, and MS in Biochemistry from the Albert Einstein College of Medicine in New York, where he focused on molecular interactions in biological systems. Before that, he completed both a BA in Chemistry and Molecular Biology & Biophysics and an MA in Chemistry from Wesleyan University in Middletown, CT. His doctoral work explored protein-RNA interactions, laying the groundwork for his scientific rigor and precision. This strong biochemical foundation supports his innovative clinical research in radiation oncology and immunotherapy. His education highlights a consistent pattern of academic excellence and intellectual curiosity, equipping him with a rare blend of clinical insight and research acumen that continues to impact cancer treatment paradigms worldwide.

Professional Experience:

Dr. Dukagjin Blakaj is the Vice Chair of Clinical Operations in Radiation Oncology and Drs. Malati and Ganesh Potdar Endowed Professor in Proton Therapy at OSUCCC – James Cancer Hospital. As a senior faculty member, he has led transformative improvements in clinical care, quality assurance, and translational oncology research. His multidisciplinary collaboration extends across surgery, radiology, oncology, and data science, driving innovations such as AI-guided treatment protocols and digital health integration. Dr. Blakaj has also played a critical role in operationalizing proton therapy and implementing personalized cancer therapies. His background spans high-impact clinical trials, program development, and mentorship. The combination of clinical leadership and academic scholarship positions him as a strategic thinker with practical, evidence-driven execution. His commitment to precision medicine and patient-centered care distinguishes him among modern radiation oncologists.

Awards and Honors:

Dr. Blakaj has received numerous accolades that reflect his clinical excellence, research innovation, and service to the academic community. Notably, he was awarded the Drs. Malati and Ganesh Potdar Endowed Professorship in Radiation Oncology – Proton Therapy (effective June 2025), the highest honor granted by Ohio State University. His ABR Volunteer Service Award (July 2025) highlights his contributions to professional standards and education. He was selected for the James Outstanding Physician Peer Award for exemplary leadership, professionalism, and collaboration (August 2024). Additionally, his abstract ranked in the Top 7 of 146 presentations at ACRO, underscoring his research’s national impact. Dr. Blakaj’s consistent recognition across service, research, and teaching is a testament to his dedication, integrity, and influence in the field of oncology.

Research Focus:

Dr. Blakaj’s research is centered on optimizing cancer treatment outcomes through precision radiation therapy, immunotherapy integration, and the application of artificial intelligence in oncology. He focuses primarily on head and neck cancers, with additional emphasis on HPV-associated oropharyngeal carcinoma, FLASH radiotherapy, and treatment response prediction using circulating tumor DNA and inflammatory indices. He co-leads interdisciplinary studies leveraging machine learning, big data, and digital health tools to personalize care and reduce treatment toxicity. His research is both translational and clinically grounded, often influencing national clinical practice guidelines and multi-center trials. As a key contributor to high-impact publications, Dr. Blakaj has established himself as a thought leader in adaptive radiotherapy and survivorship outcomes. His pioneering work in proton therapy protocols and patient-reported outcomes continues to bridge the gap between innovative science and practical oncology care.

Publications Top Notes: 

  1. An integrated ML-based prognostic model in head and neck cancer using inflammatory markers and financial toxicity

  2. Vertebral endplate disruption and compression fracture risk: Expanded radiotherapy analysis

  3. Nasopharyngeal carcinoma in nonendemic regions: Characteristics and treatment outcomes

  4. Emerging paradigms in radiation oncology: Evolution and patient-centric care

  5. FLASH radiotherapy: From in vivo data to clinical translation

  6. Digital health tools in radiation oncology: Development and implementation review

  7. ctDNA as a response marker in HPV-associated oropharyngeal carcinoma: A pilot study

  8. AI, machine learning, and big data in radiation oncology

  9. Predicting cisplatin tolerability in elderly head and neck cancer patients

  10.  Tobacco, marijuana, and alcohol use impact on survival in metastatic head and neck cancer

Conclusion:

Dr. Dukagjin M. Blakaj is a highly qualified, forward-thinking researcher whose body of work exemplifies excellence in translational oncology. He brings together advanced clinical practice, cutting-edge research, and visionary leadership to improve cancer care outcomes and drive future innovations in radiation therapy.

Given his sustained productivity, multidisciplinary leadership, and contributions to patient-centered care models, Dr. Blakaj is a deserving and outstanding nominee for the Best Researcher Award.

Marco Leitzke | immunology | Best Researcher Award

Published on by Cell Biologist

Dr. Marco Leitzke | immunology | Best Researcher Award

Dr. Marco Leitzke, Helios clinics, Germany

Dr. Marco Leitzke, born in 1970 in Karl-Marx-Stadt, Germany, is a senior anesthesiologist and pioneering researcher in neuromodulation and post-viral syndromes. He has served as Senior Consultant in Anesthesiology and Intensive Care at Helios Clinic Leisnig since 2015 and has extensive experience in pain therapy and palliative medicine. Renowned for his innovative studies on autonomic dysfunction, Dr. Leitzke has published extensively on cholinergic neurotransmission, COVID-19 coagulopathy, and vagus nerve stimulation. His recent focus on Long COVID as a disorder of disrupted acetylcholine signaling has gained significant scientific attention. With a dual career in clinical practice and experimental research, he bridges the gap between bedside and bench. His work earned him accolades, including a Poster Award at the 1st Long COVID Congress in Jena. Passionate about translational medicine, Dr. Leitzke continues to drive forward the understanding and treatment of complex neuroimmune disorders.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Leitzke’s medical education and specialization reflect a deep commitment to anesthesiology and neurobiological research. He became a board-certified specialist in anesthesiology in 2006 and has built on this foundation with focused training in advanced pain management, ultrasound-guided interventions, and emergency medicine. He undertook specialized pain therapy training in 2015 and interventional pain techniques in 2014. In 2019, he began training as an Antibiotic Stewardship (ABS) expert physician, further demonstrating his holistic approach to patient safety and infection control. He also completed a transthoracic echocardiography course in 2018, showcasing his commitment to continuous learning and cross-disciplinary skills. This diverse academic background provides the basis for his translational research into neuroimmune and autonomic disorders, with a strong emphasis on clinical application. His combination of anesthesiology, ultrasound, pain therapy, and experimental neurobiology positions him as a uniquely skilled researcher bridging clinical practice and neuroscience.

Experience:

Dr. Marco Leitzke brings over two decades of clinical experience, predominantly in anesthesiology, intensive care, pain therapy, and palliative medicine. Since 2015, he has held the position of Senior Consultant at the Helios Clinic in Leisnig, where he leads interdisciplinary efforts in patient care and clinical innovation. Prior to this, he served as Senior Consultant at Asklepios Clinic Weißenfels from 2011 to 2014, while also operating as a freelance physician in Zeitz. His professional focus spans acute and chronic pain, complex anesthesia procedures, and critical care management, underpinned by a solid emergency medicine foundation gained since 2001. His hands-on experience with ultrasound-guided interventions, vagal modulation therapies, and autonomic diagnostics directly informs his research into the pathophysiology of post-viral syndromes. The integration of clinical insight and scientific exploration marks him as a dual-domain expert, fostering new therapeutic approaches rooted in both laboratory evidence and patient outcomes.

Research Focus:

Dr. Leitzke’s research centers on cholinergic neurotransmission and its impairment in acute and chronic post-viral conditions, particularly Long COVID. His central hypothesis suggests that autonomic dysfunction and neuromodulatory imbalance—specifically, disruption of the vagus nerve and acetylcholine pathways—underlie many post-viral symptoms. Through translational models using animal studies and human imaging, he explores therapeutic modulation, including vagal nerve stimulation and nicotine administration, to restore autonomic balance. His research extends to the role of NF-κB activation in COVID-19-associated coagulopathy, suggesting molecular pathways that link inflammation, clotting, and neuroimmune dysfunction. A hallmark of his work is the use of advanced imaging techniques (e.g., PET scans) to quantify cerebral receptor activity, particularly α7 nicotinic acetylcholine receptors. This integrative and experimental approach offers new perspectives on diagnostics and treatment in neuroimmune conditions, making his work highly relevant to both the scientific and medical communities in the era of post-COVID syndromes.

Publications Top Notes:

  1. 📖 Long COVID – A Critical Disruption of Cholinergic Neurotransmission? (Springer Nature, 2025)

  2. 📖 Is the Post-COVID-19 Syndrome a Severe Impairment of Acetylcholine-Orchestrated Neuromodulation That Responds to Nicotine Administration? (Springer Nature, 2023)

  3. 🏅 COVID-19 – The Ultimate NF-κB Rush and the Crucial Importance of Nicotinic Acetylcholine Receptors (Poster Award, Long COVID Congress, 2022)

  4. 🔬 Experimental Design for PET Detection of α7nAChR Under Gastric Vagus Nerve Stimulation in Piglets (DAS PLUS AN SCHUTZ, 2022)

  5. 🧠 The Viral Accelerated NF-κB Pathway and COVID-19-Associated Coagulopathy – A Case Report (Fortune Journals, 2021)

  6. 🧪 Afferent Vagal Stimulation via Gastric Electrical Stimulation Alters Sympathetic-Vagal Balance in Pigs – A Pilot Trial (Journal of Biological Regulators, 2021)

  7. ⚖️ Autonomic Balance Determines the Severity of COVID-19 Courses (Springer Nature, 2020)

  8. 🧮 A Semi-Automated Algorithm for Hypothalamus Volumetry in 3 Tesla MRI (Psychiatry Research: Neuroimaging, 2018)

  9. 🧬 Image-Derived Input Function for (-)-[18F]Flubatine Using a Digital PET System (European Journal of Nuclear Medicine, 2024)

  10. 💊 What Is the Impact of Nicotine on the Post-COVID-19 Syndrome? – A Case Series (Preprint, 2025)

Conclusion:

Dr. Marco Leitzke is a highly deserving candidate for the Best Researcher Award due to his pioneering contributions to understanding and treating Long COVID and neuroimmune disorders. His strong publication record, interdisciplinary approach, and clinical insight mark him as a leading figure in his field. With enhanced international collaboration and clinical validation of his findings, his impact could be even greater. Overall, his research is timely, innovative, and of substantial scientific and societal importance.

Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Dr. Michel Manika Muteya, Faculty of Medicine, University of Lubumbashi, Congo, Democratic Republic of the

Dr. Michel Manika Muteya is a seasoned Congolese physician, specializing in Anesthesiology, Intensive Care, and Emergency Medicine. Born in Lubumbashi on September 5, 1972, he has dedicated over two decades to both clinical excellence and academic research. As Head of the Anaesthesiology-Intensive Care Department at the University Teaching Hospital of Lubumbashi since 2013, Dr. Muteya is recognized for advancing critical care practices in resource-limited settings. His scientific contributions, spanning over 20 peer-reviewed publications, tackle pressing health issues like sepsis, tuberculosis, transfusion medicine, and maternal care. A married father of five, he balances his demanding career with strong family values. With a collaborative spirit and global engagements, he contributes to large-scale studies including the ASOS-2 Lancet Trial, reflecting his impact in African surgical safety. His leadership and evidence-based approach make him a top contender for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Michel Muteya Manika received his Doctor of Medicine (MD) degree after completing an intensive medical program that included a year-long rotating internship (2003–2004) at Sendwe Hospital in Lubumbashi, covering internal medicine, pediatrics, surgery, and gynecology. He further honed his skills through a professionalization internship in General Medicine at the Ruashi Military Hospital (HMR) from November 2004 to May 2005. His specialization journey led him into the field of Anesthesiology and Intensive Care, where he developed key competencies in transfusion medicine, disaster medicine, and emergency response. In parallel, he has continually upgraded his academic profile by engaging in international conferences, research collaborations, and multi-country studies. His educational path reflects a strong clinical foundation coupled with academic curiosity, enabling him to bridge practical medicine with impactful research in sub-Saharan Africa.

Experience:

Dr. Michel Manika Muteya has served as the Head of Anaesthesiology and Intensive Care at the University Teaching Hospital of Lubumbashi since 2013. His leadership has driven improved patient outcomes and department-wide protocols, especially for sepsis, trauma, obstetric emergencies, and postoperative care. His hands-on training began with internships in internal medicine, pediatrics, surgery, and gynecology, followed by a professionalization period at a military hospital. With more than 20 years of clinical and academic experience, Dr. Muteya has also contributed to policy and training reforms in anesthesia education, collaborating with international teams in Rwanda and beyond. He’s a mentor, educator, and published researcher, involved in critical studies related to infectious diseases, HIV, malaria, and emergency care readiness. His commitment to healthcare in resource-limited environments underlines his passion for equitable, safe, and effective care, making his career a beacon of medical excellence in Central Africa.

Research Focus:

Dr. Michel Muteya Manika’s research primarily focuses on critical care medicine in low-resource settings, with specific interests in sepsis management, transfusion medicine, anesthetic safety, and infectious diseases such as tuberculosis and HIV. He investigates both the clinical and epidemiological aspects of disease patterns in the Democratic Republic of Congo, often exploring how infrastructure limitations affect care outcomes. His work extends to maternal and pediatric emergencies, post-operative surveillance, and clinical education reform, including developing curricula for anesthesiology clerkships in Africa. He collaborates widely across disciplines and borders, contributing to high-impact journals like The Lancet Global Health, BMC Health Services Research, and Pan African Medical Journal. A champion of evidence-based practice, Dr. Muteya seeks to align global standards with local realities, enhancing emergency response systems and training the next generation of African clinicians. His applied, context-specific research offers real-world solutions to systemic healthcare challenges.

Publications Top Notes: 

  1.  Prognosis of Tetanus Patients in ICU – Sendwe Hospital, Lubumbashi

  2.  Epidermoid Carcinoma of the Vulva in Twin Pregnancy – Case Report

  3.  Tuberculosis Revealed by Thrombocytopenic Purpura in a Child

  4.  Anemias in Pediatric Emergencies – 632 Cases Study

  5.  Peripheral Lymphadenopathy: Tertiary Center Study

  6.  Cytopathological Profile of Lymphadenopathies – 13 Cases

  7.  Malaria/HIV Coinfection Profile in Lubumbashi Adults

  8.  Seroprevalence of Blood Donors – University Clinics of Lubumbashi

  9.  Tuberculosis Profile in Lubumbashi Health Zone

  10.  Anesthesia Practices in Lubumbashi – Patient and Surgery Types

Conclusion:

Dr. Michel Manika Muteya is highly suitable for the Best Researcher Award. He combines clinical leadership, regional relevance, and consistent academic output in fields critical to healthcare improvement in Africa. His research addresses real-world health crises—sepsis, HIV, TB, surgical safety—through practical, evidence-based approaches. With a balance of hands-on expertise and scholarly excellence, he represents the ideal candidate whose work has both academic rigor and societal impact. Minor expansions in global visibility and technological integration would elevate his already impressive career to even greater heights.

Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Published on by Cell Biologist

Dr. Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Dr. Jebunnahar Khandakar, Independent University, Bangladesh, Bangladesh

Dr. Jebunnahar Khandakar is an accomplished academic and researcher specializing in environmental science, plant physiology, and biotechnology. Currently serving as an Associate Professor in the Department of Life Sciences at Independent University, Bangladesh, she brings extensive expertise in sustainable agriculture and mushroom biotechnology. She earned her PhD from Nagasaki University, Japan, with a focus on plant-environment interactions and proteomics. Over her career, Dr. Khandakar has contributed significantly to research in mushroom cultivation, environmental sustainability, and food system innovations. Her work has been published in renowned journals, reflecting her commitment to developing practical, affordable, and eco-friendly solutions for agricultural improvement. She has also provided consultancy for global initiatives, including work with the UNCCD. Dr. Khandakar’s dedication to research and community impact makes her a strong candidate for recognition as a Best Researcher Award recipient.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Jebunnahar Khandakar’s educational background demonstrates a strong foundation in biotechnology and environmental science. She earned her Doctor of Philosophy (PhD) in September 2013 from Nagasaki University, Japan, where she focused on plant physiology and biotechnology, specifically analyzing stress responses and secondary metabolism in plants. Prior to that, she completed her MS in Biotechnology in July 2005 from Bangladesh Agricultural University with an excellent academic record (Grade A). Her MS research delved into mycelial growth and spawn production, forming the basis for her long-term interest in fungal biology. These degrees have equipped her with expertise in both applied and fundamental biosciences, particularly in sustainable crop production and biotechnological applications for food and environmental security. Her strong academic background supports her ongoing contributions to science through teaching, mentoring, and pioneering research projects.

Experience:

Dr. Jebunnahar Khandakar has nearly two decades of combined experience in academia and applied environmental science. She is currently an Associate Professor at Independent University, Bangladesh (IUB), where she has served since 2016, being promoted in September 2024. At IUB, she teaches and supervises students in plant biotechnology, environmental biology, and sustainable agriculture. Before her academic tenure, she served as a Junior Consultant for the United Nations Convention to Combat Desertification (UNCCD) at the Department of Environment in Dhaka, where she contributed to policy frameworks for sustainable land use and biodiversity conservation. Her role involved integrating scientific research into national strategies, further enriching her interdisciplinary understanding. Dr. Khandakar’s career trajectory highlights her ability to bridge academic knowledge with field applications, aligning science with real-world agricultural and environmental challenges.

Research Focus:

Dr. Khandakar’s research primarily centers on sustainable agriculture, environmental biotechnology, and fungal physiology. Her work spans optimizing substrates for mushroom cultivation, improving post-harvest shelf life, and exploring biowaste as cultivation media. She also explores molecular and physiological responses of medicinal plants like Hyoscyamus albus under abiotic stresses, including nutrient deficiencies and metal toxicity. Through proteomics and biochemistry, she investigates root signaling, riboflavin biosynthesis, and stress-induced metabolite changes. Recently, her research has shifted to low-cost, eco-friendly solutions for food production—developing nitrogen gas packaging for mushrooms and assessing market chains for semi-fermented fish. Her interdisciplinary approach blends biotechnology with environmental sustainability, aiming to improve nutrition, soil health, and farmer livelihoods. This diverse yet focused research portfolio underlines her impact and innovation in agricultural and life sciences, with clear contributions toward climate-smart and affordable food technologies.

Publications Top Notes: 

  1. Using spent mushroom substrate (SMS) as a casing boosted bacterial activity and enhanced the mineral profile of Calocybe indica.

  2. Deciphering the Role of Substrate C/N Ratio in Preventing Orange Mold Contamination in Mushroom Cultivation.

  3. Establishment of a Simple Single Spore Isolation Method for Gilled Mushroom Research.

  4. Optimizing Tea Waste as a Sustainable Substrate for Oyster Mushroom Cultivation.

  5. Packaging with Nitrogen Gas Enhanced Shelf-Life of Fresh Oyster Mushrooms.

  6. Exploring the Market Value Chain Dynamics of Chepa (Semi-Fermented Fish).

  7. Shelf-life Evaluation of Oyster Mushrooms using Different Packaging Materials and Storage Conditions.

  8. Survey on Technical Efficacy and Farmer Satisfaction for Onion Seed Production in Rajshahi.

  9. Extraction and Fractionation of Subproteome from Hyoscyamus albus Root Tips.

  10.  Reducing Pesticide Use in Cucumber Cultivation via Environment-Friendly Technology.

Conclusion:

Dr. Jebunnahar Khandakar is highly deserving of the Best Researcher Award. Her work is innovative, impactful, and highly aligned with real-world agricultural challenges—particularly in low-cost, sustainable food production methods and environmental biotechnology. She has demonstrated academic excellence, field application, and research leadership over the years, both nationally and internationally.

Catherine Stanton | Microbiome | Best Researcher Award

Published on by Cell Biologist

Prof. Catherine Stanton | Microbiome | Best Researcher Award

Prof. Catherine Stanton, Teagasc Food Research Centre, Ireland

Prof. Catherine Stanton is a globally recognized expert in nutrition, microbiology, and food science, currently serving as a Senior Principal Research Officer at Teagasc Moorepark, Ireland, and Research Professor at University College Cork. With an H-index of 135 (Google Scholar), her groundbreaking work in probiotics, gut microbiota, and dairy science has made substantial contributions to human and animal health. She is a Principal Investigator at APC Microbiome Ireland, shaping key insights into microbial-host interactions. Prof. Stanton’s interdisciplinary expertise spans biochemistry, food bioscience, and microbiome research, making her a leader in functional foods innovation. Over her career, she has authored hundreds of publications, filed multiple patents, and earned global recognition as a highly cited researcher. She is renowned for translating science into applications in nutrition and health, benefiting industries and public health policies alike.

Publication Profile: 

Scopus

Education:

Prof. Stanton holds a distinguished academic background rooted in nutrition and biochemistry. She earned her B.Sc. in Nutrition & Food Chemistry from University College Cork (UCC) in 1983, achieving second-class honours (2.1). She followed this with an M.Sc. in Nutrition at UCC in 1986, gaining a deeper understanding of food-based health science. In 1988, she completed her Ph.D. in Biochemistry at Bournemouth University, UK, focusing on molecular and functional biochemistry. Her pursuit of academic excellence culminated in receiving a D.Sc. from the National University of Ireland in 2009, a testament to her lifetime achievements in research. These academic milestones laid the foundation for her multidisciplinary approach, bridging nutrition, microbiology, and food technology to tackle pressing health challenges. Her educational journey reflects both depth and breadth, enabling her to excel in academic research, innovation, and international collaboration.

Experience:

Prof. Stanton has over three decades of impactful research and leadership in microbiology and nutrition. Since 2018, she has served as Senior Principal Research Officer at Teagasc Moorepark, Ireland’s leading agri-food research institute. She is also a Research Professor at University College Cork (UCC) and a Principal Investigator at APC Microbiome Ireland since 2003, where she spearheads cutting-edge research into gut microbiota, probiotics, and host health. Her academic career is complemented by her industrial collaborations, public policy contributions, and work with global health organizations. Prof. Stanton’s innovative patents and translational science have impacted sectors ranging from dairy to pharmaceuticals. She has mentored countless students and professionals while representing Ireland on international expert panels such as the FAO/WHO Probiotics Consultation. Her tenure showcases a rare blend of scientific excellence, leadership, and collaborative prowess.

Awards and Honours:

Prof. Stanton has received numerous prestigious accolades for her scientific contributions. She was named a Highly Cited Researcher by Web of Science (Clarivate Analytics) from 2017 to 2024, placing her among the top 1% globally in Agricultural Science and Microbiology. In 2020, she was honoured with the Distinguished Service Award by the American Dairy Science Association (ADSA), recognizing her lifetime achievements. In 2019, she was declared Scientist of the Year at the Irish Laboratory Awards, acknowledging her leadership in microbiome and functional foods research. She also served as Rapporteur for the FAO/WHO Expert Consultation on Probiotics in Food (2001), contributing to global food health policies. Her awards reflect not only the depth of her research but also its real-world impact in agriculture, nutrition, and global health policy, making her a standout in interdisciplinary scientific leadership.

Research Focus:

Prof. Stanton’s research centers on functional foods, probiotics, and the gut microbiome, focusing on their roles in human and animal health. Her work investigates the mechanisms of beneficial microbes, particularly how they influence immune function, intestinal integrity, and disease prevention. She has pioneered research on conjugated linoleic acids, probiotic cheese development, and bacteriocin-producing strains that combat pathogens. At APC Microbiome Ireland, she leads projects exploring maternal and infant gut health, developing microbiota-based strategies for conditions ranging from diarrhea to cancer. Her research is highly translational, often leading to patents and industry applications in food biotechnology and pharmaceuticals. She collaborates across disciplines—biochemistry, microbiology, and nutrition—to develop evidence-based dietary interventions. With a strong publication record and global influence, her research has set benchmarks in microbiome science, making her a leader in shaping next-generation health strategies.

Publications Top Notes: 

  1. Leuconostoc lactis strain APC 3969 produces a new variant of cyclic bacteriocin leucocyclicin Q and displays potent anti-Clostridium perfringens activity

  2. Bacteroides maternus sp. nov., a novel species isolated from human faeces

  3. Gut and oral microbial profile associations to oral cancer

  4. Bifidobacterium longum subsp. infantis modulates intestinal immunity in growing mice in a strain-specific manner

  5. Exploring tarhana’s prebiotic potential using different flours in an in vitro fermentation model

  6. Lactiplantibacillus plantarum CCFM8661 improves intestinal barrier function and regulates gut microbiota to alleviate enterotoxigenic E. coli-induced diarrhea in mice

  7. Rebuttal to Gut Microbiome in Children with Congenital Heart Disease After Cardiopulmonary Bypass Surgery (GuMiBear Study)

  8. Correction to: Examining the healthy human microbiome concept

  9. Examining the healthy human microbiome concept

  10. Streptococcus wuxiensis, S. jiangnanensis, and S. fermentans: three novel species isolated from human breast mil

Conclusion:

Prof. Catherine Stanton is eminently suitable for the Best Researcher Award, based on her scientific excellence, real-world impact, and global recognition. Her body of work demonstrates visionary leadership, interdisciplinary collaboration, and a legacy of innovation in probiotics and microbiome science. With unmatched citation metrics, patent contributions, and public service roles, she stands as a role model for both established and upcoming researchers.

Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Prof. Hansong Dong, Shandong Agricultural University, China

Dr. Hansong Dong is a distinguished Professor of Plant Pathology and Doctoral Supervisor at Shandong Agricultural University, China. With a Ph.D. in Plant Pathology, his work spans over four decades, focusing on plant immunity, signal transduction, and the balance between crop growth and defense. A renowned researcher and published poet, Prof. Dong has made seminal contributions to our understanding of aquaporins, hormone signaling, and the molecular interface between host plants and pathogens. His international academic exposure, including time as a Visiting Scholar at Cornell University, has further enriched his scientific insights. In addition to his impactful research, Prof. Dong has mentored numerous graduate students and contributed to agricultural innovation. With numerous high-impact publications in journals like Molecular Plant and New Phytologist, his work is widely recognized. Beyond academia, his literary works reflect a philosophical appreciation of nature and resilience, exemplifying a rare integration of science and art.

Publication Profile: 

Scopus

Education:

Prof. Hansong Dong pursued his undergraduate studies in Plant Protection at Shandong Agricultural University (1978–1982). He continued with his Master’s and Ph.D. in Plant Pathology at Nanjing Agricultural University, completing them in 1985 and 1988, respectively. His academic training provided a solid foundation in plant-microbe interactions, molecular biology, and host defense mechanisms. During his studies, he honed his focus on understanding plant immune responses, laying the groundwork for his future breakthroughs in signaling and aquaporin-mediated defense. His Ph.D. thesis contributed to early models of pathogen-host dynamics in crops, marking the start of a lifelong research trajectory in agricultural biotechnology. His formal education not only established his credibility in plant pathology but also shaped his vision for interdisciplinary research. Prof. Dong’s academic excellence has continued to drive forward key discoveries in the field, making him a leading authority in crop protection and molecular plant immunity in China and internationally.

Experience:

Prof. Dong began his career as a Lecturer in the Department of Plant Pathology at Shandong Agricultural University (1988–1993). He quickly rose through academic ranks—Associate Professor in 1993, and full Professor by 1994. His leadership and research capabilities were recognized early on, leading to a Visiting Scholar position at Cornell University (1997–2000), where he engaged in collaborative projects on plant immune signaling and pathogen effectors. Over his decades of teaching and research, Prof. Dong has supervised numerous doctoral students, published extensively, and shaped academic policy and curriculum in plant pathology. His tenure at Shandong Agricultural University is marked by scientific rigor, mentorship, and impactful agricultural innovations. His ability to bridge laboratory research with field application has contributed significantly to crop disease management strategies in China. Prof. Dong remains actively involved in national and international research initiatives, playing a vital role in advancing molecular plant pathology and crop resilience.

Awards & Honors:

Prof. Hansong Dong has received several prestigious accolades recognizing his early and sustained contributions to science and education. In 1992, he was honored as an Outstanding Young Intellectual and received the Shandong Youth Science and Technology Award, acknowledging his early promise in agricultural research. The same year, he was also named an Excellent Young Teacher, a testament to his pedagogical contributions. In 1993, he was recognized as a New Long March Commando, symbolizing excellence in youth-led scientific advancement in China. These early recognitions paved the way for a prolific academic career that has garnered respect across disciplines. His awards highlight his leadership in scientific innovation, commitment to nurturing the next generation of researchers, and the societal relevance of his work in safeguarding global food security. As both a scientist and educator, Prof. Dong’s accolades reflect his well-rounded excellence and continued influence in plant pathology and agronomic science.

Research Focus:

Prof. Dong’s research focuses on signal transduction in plant disease resistance and the regulation of growth-defense trade-offs in crops. His work investigates the molecular dialogue between plants and pathogens, particularly through the lens of aquaporins, importins, and membrane proteins. He has significantly advanced our understanding of how pathogenic effectors manipulate host splicing and hormone pathways, notably through TAL effectors and NPR1/NPR3 systems in rice. His team applies multi-omics and CRISPR-based editing to engineer resistant crops while minimizing yield penalties, a critical goal in sustainable agriculture. By elucidating the roles of H2O2 transport, type-III secretion systems, and transcriptional regulation, his research offers translational solutions to fungal and bacterial diseases in cereals like rice and wheat. Prof. Dong’s innovative blend of molecular biology, bioinformatics, and field experimentation drives progress toward disease-resilient, high-yield crops. His collaborative, systems-level approach continues to shape modern plant pathology and crop biotechnology.

 Publications Top Notes:

  1. Alternative splicing of OsNPR3… enhances disease susceptibility in rice – Molecular Plant, 2025

  2. Plant PI4P is required for bacteria to translocate type-3 effectors – New Phytologist, 2025

  3. MYB44 regulates PTI via EIN2 and MPK3/6 in Arabidopsis – Plant Communications, 2023

  4. Importin β1 mediates nuclear entry of EIN2C against aphids – IJMS, 2023

  5. Phosphorylation of wheat aquaporin enhances growth and defense – Molecular Plant, 2022

  6. Aquaporin OsPIP2;2 links H2O2 signaling to plant defense – Plant Physiology, 2022

  7. Editing rice importin IMPα1b sequesters TAL effectors – Phytopathology Research, 2022

  8. Aquaporin modulation intensifies photosynthesis and disease resistance – Plant Journal, 2021

  9. OsPIP2;2 facilitates drought tolerance in rice – Plant Direct, 2021

  10.  Aquaporin TaPIP2;10 confers dual fungal resistance in wheat – Phytopathology, 2021

Conclusion:

Prof. Hansong Dong is highly suitable for the “Best Researcher Award.” His scholarly depth, sustained academic leadership, groundbreaking findings in plant pathology, and dedication to mentoring make him a standout candidate. His career exemplifies a blend of scientific rigor, poetic vision, and global relevance. Recognizing Prof. Dong would not only honor an exceptional researcher but also inspire younger generations in the intersection of science and humanity.

Takwa Wannassi | Plant pathology | Best Researcher Award

Published on by Cell Biologist

Dr. Takwa Wannassi | Plant pathology | Best Researcher Award

Dr. Takwa Wannassi, CRRA Sidi Bouzid, Tunisia

Dr. Takwa Wannassi is a dedicated plant protection specialist and postdoctoral researcher at the Regional Center of Agricultural Research in Sidi Bouzid, Tunisia. With a Ph.D. in Plant Protection and Environment and an Engineering Degree in Horticulture, she brings advanced expertise in entomology, plant-microbe interactions, and sustainable agriculture. Her work is primarily focused on integrated pest management and ecological approaches to crop protection, particularly in Mediterranean agroecosystems. Dr. Wannassi has authored several impactful scientific publications and has contributed significantly to the understanding of invasive pest dynamics, particularly the apricot seed wasp. She plays a crucial role in the international PRIMA project “REVINE,” where she coordinates field trials, mentors students, and collaborates across scientific disciplines. Her dedication to sustainable farming solutions, her extensive research record, and her collaborative spirit make her a strong candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar
Scopus
Orcid

Education:

Dr. Takwa Wannassi holds a Ph.D. in Plant Protection and Environment from Sousse University, Higher Institute of Agronomic Sciences of Chott Mariem (ISA-CM), completed in December 2022. Her doctoral work centered on invasive species and sustainable pest management in Tunisia, particularly the apricot seed wasp Eurytoma samsonowi. She also holds an Engineer Degree in Horticulture with a specialization in Plant Protection, earned in July 2017 from the same institution. Her academic journey reflects a consistent focus on understanding ecological challenges in agriculture and developing innovative, sustainable solutions. Through both degrees, she acquired hands-on skills in molecular biology, field experimentation, pest identification, and biological control. Her academic excellence laid the foundation for her impactful contributions in agricultural research and sustainability science in the Mediterranean region.

Experience:

Since January 2025, Dr. Takwa Wannassi has been serving as a postdoctoral fellow at the Regional Center of Agricultural Research in Sidi Bouzid (CRRA), Tunisia, contributing to the international PRIMA Project “REVINE.” Her responsibilities include coordinating the research project, supervising graduate students, conducting field and lab trials, and analyzing data using R. Her work spans genomic analysis, molecular diagnostics, pest ecology, and microbiome studies. Previously, during her Ph.D., she gained extensive experience in pest ecology, molecular biology, and entomology, particularly in relation to invasive pests such as Eurytoma samsonowi. Dr. Wannassi also collaborates with international institutions, including during a research fellowship in Canada. She is proficient in preparing scientific publications and has presented her findings at major international conferences. Her multidisciplinary approach and leadership in sustainable agriculture research have earned her recognition at both national and international levels.

Awards and Honors:

Dr. Takwa Wannassi has received several accolades in recognition of her contributions to agricultural science and research. In 2019, she earned the Best Poster Award at the Tunisia-Japan Symposium on Science, Society and Technology (TJASSST) for her research on pest behavior and pheromone-based management strategies. That same year, she was granted a Research Fellowship in Canada, allowing her to work at the University of Victoria, British Columbia for two months, enhancing her international research exposure and collaboration. Her continuous efforts in sustainable pest management, microbiome studies, and plant-pathogen interaction have positioned her as a promising researcher in plant protection. She is frequently invited to contribute to scientific conferences and peer-reviewed journals. Her achievements underline her scientific innovation, dedication to eco-agriculture, and her potential as a future leader in Mediterranean agricultural research.

Research Focus:

Dr. Takwa Wannassi’s research centers on plant protection, pest ecology, biological control, and plant-microbiome interactions, with a strong focus on sustainability. Her main scientific interest lies in understanding the behavior and biology of invasive pests like Eurytoma samsonowi, a major threat to apricot production in Tunisia. She utilizes molecular tools, including 16S rRNA sequencing, to explore bacterial communities and Wolbachia infections in pest populations. Additionally, she investigates the role of beneficial rhizobacteria and microbial consortia in disease suppression and grapevine health as part of the PRIMA “REVINE” project. Through multidisciplinary approaches, she integrates entomology, microbiology, and bioinformatics to develop innovative pest management strategies aligned with climate-smart agriculture. Her goal is to promote ecosystem services, biodiversity, and resilience in Mediterranean cropping systems through regenerative and eco-friendly practices.

Publications Top Notes: 

  1. Insights on the bioecology of the invasive apricot seed wasp Eurytoma samsonowi in Tunisia (Biologia, 2023)

  2. Emergence of the apricot seed wasp Eurytoma samsonowi as an economic pest of apricots in Tunisia (Phytoparasitica, 2022)

  3. Prevalence of Wolbachia infection in field populations of the apricot seed wasp (International Microbiology, 2024)

  4. Exploration of bacterial composition and diversity within Eurytoma samsonowi via 16S rRNA sequencing (Symbiosis, 2025)

  5. Harnessing a Microbial Consortium and Compost to Control Grapevine Pathogens (Horticulturae, 2025)

  6. Investigating the potential role of beneficial rhizobacteria for grapevine health and growth (Frontiers in Sustainable Food Systems, 2025)

  7. Biocontrol Assessment of Trichoderma Species on Tomato Crops Infested by Curvularia Spicifera (Frontiers, 2025)

  8. Divergent bacterial abundance and diversity in Eurytoma samsonowi revealed by 16S rRNA (Biochem & Microbiology Congress)

  9. Assessment of damage by Eurytoma samsonowi on apricot fruits in Tunisia (INAT Symposium Poster, 2018)

  10.  Delta traps with virgin females attract Eurytoma samsonowi males: Pheromone control potential (TJASSST, 2019)

Conclusion:

Dr. Takwa Wannassi is an emerging leader in plant protection and agroecology, with a proven record of excellence in research, publishing, and project management. Her work on invasive pest control, microbial consortia, and regenerative viticulture directly addresses critical challenges in Mediterranean and global agriculture. Her multidisciplinary approach, international recognition, and active mentorship highlight her readiness for continued leadership in science. She is highly suitable and deserving of the Best Researcher Award, as she exemplifies innovation, academic rigor, and a commitment to sustainable agricultural development.

Cesare Orlandi | GPCR signaling pathways | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Cesare Orlandi | GPCR signaling pathways | Best Researcher Award

Assoc. Prof. Dr. Cesare Orlandi, University of Rochester, United States

Dr. Cesare Orlandi is an accomplished Associate Professor of Pharmacology and Physiology at the University of Rochester School of Medicine & Dentistry. With a multidisciplinary background in pharmaceutical biotechnology and molecular genetics, Dr. Orlandi has made significant contributions to GPCR (G protein-coupled receptor) biology, orphan receptor deorphanization, and signal transduction. His work bridges basic molecular pharmacology with translational applications in neuroscience and immunology. He has authored numerous high-impact publications in leading journals like Science, Nature Communications, and Journal of Medicinal Chemistry. His collaborative research with global institutions reflects a strong network and broad scientific reach. Recognized for his excellence in science communication, Dr. Orlandi has received multiple “Best Talk” awards at competitive research symposia. His lab continues to innovate at the frontier of receptor biology, influencing therapeutic strategies in neurobiology and inflammation.

Publication Profile: 

Scopus

Orcid

Strengths for the Award:

  1. High-Impact Publications in Prestigious Journals
    Dr. Orlandi has published in top-tier, peer-reviewed journals, including Science, Nature Communications, PNAS, Journal of Physiology, and Molecular Pharmacology. This reflects the scientific rigor, innovation, and broad relevance of his work.

  2. Research Innovation in GPCR Biology
    His research into orphan G protein-coupled receptors (GPCRs) has led to the development of new experimental assays (e.g., GzESTY) and has provided significant insights into immune and neurological signaling mechanisms. These contributions are not only fundamental but also highly translational, aligning with drug discovery and therapeutic interventions.

  3. Strong Interdisciplinary and Collaborative Profile
    Dr. Orlandi’s collaborations with diverse teams across pharmacology, structural biology, and immunology underscore his interdisciplinary approach. His name appears alongside experts from multiple institutions, showing leadership in team science.

  4. Recognition for Scientific Communication
    His awards for Best Talk at Scripps Research Fest (2016, 2018) and selection for a Gordon Research Seminar oral presentation affirm his strength in communicating complex science effectively—an essential trait for broader impact.

  5. Mentorship and Leadership
    As an Associate Professor at the University of Rochester, Dr. Orlandi plays an active role in training the next generation of biomedical researchers, contributing to capacity building in academia.

Areas for Improvement:

  1. Limited Mention of Funding Sources or Grant Leadership
    While his publication record is excellent, there’s no clear listing of major research grants or principal investigator (PI) roles, which are critical markers for research independence and sustainability.

  2. More Visible Clinical or Translational Output
    While his work is biologically impactful, the clinical translation or patenting aspect could be made more visible to demonstrate tangible applications beyond academic impact.

  3. Leadership in International Consortia or Editorial Boards
    Additional involvement in editorial boards, scientific committees, or research policy advisory roles would further bolster his profile as a leader in his field.

Education:

Dr. Orlandi earned his Ph.D. in Molecular Genetics from the University of Brescia, Italy (2005–2009), where he conducted foundational research into genetic signaling mechanisms. Prior to that, he completed a Master of Science in Pharmaceutical Biotechnology at the University of Milan (1998–2004), equipping him with a robust interdisciplinary foundation in drug development, pharmacodynamics, and molecular biology. His academic path reflects a strong European biomedical training system, with emphasis on translational pharmacology and therapeutic innovation. The combination of pharmaceutical science and genetic research uniquely positions Dr. Orlandi to explore receptor biology with a precision medicine lens. His training was further strengthened by postdoctoral research in elite institutions, where he deepened his specialization in orphan GPCR signaling. This education forms the backbone of his research productivity and ability to mentor the next generation of molecular pharmacologists.

Experience:

Dr. Cesare Orlandi currently serves as Associate Professor in the Department of Pharmacology and Physiology at the University of Rochester. He has established himself as a leading voice in the GPCR research community, especially in understanding orphan receptors and their roles in neuronal and immune systems. Prior to this, he held postdoctoral and research positions where he collaborated with global leaders in receptor signaling and neurobiology. His lab combines pharmacological, molecular, and computational approaches to tackle fundamental questions about receptor activity, bias, and downstream signaling. With over a decade of hands-on research experience and extensive publication output, Dr. Orlandi has trained graduate students and postdocs who have progressed into independent academic and industry positions. His multidisciplinary experience spans receptor pharmacology, molecular neuroscience, and drug discovery, making him a cornerstone in collaborative biomedical research projects at the University of Rochester and beyond.

Awards and Honors:

Dr. Orlandi’s scientific excellence has been recognized with several prestigious honors. Notably, he received the Best Talk Award at the Scripps Research Fest in both 2016 and 2018, underscoring his ability to clearly and impactfully communicate complex scientific findings. In 2016, his work was also selected for an oral presentation at the highly competitive Gordon Research Seminar on Phosphorylation and G-Protein Mediated Signaling, affirming the novelty and relevance of his contributions to the receptor signaling field. These awards highlight not only the depth of his scientific insights but also his excellence in mentorship, collaboration, and thought leadership. They place him among a select group of researchers with both technical and communicative brilliance, a critical trait for academic and translational science leadership. These recognitions, combined with high-impact publications, position Dr. Orlandi as a deserving candidate for the Best Researcher Award.

Research Focus:

Dr. Orlandi’s research revolves around orphan G protein-coupled receptors (GPCRs)—a class of proteins that are vital drug targets but remain largely unexplored. His lab develops novel assays (like GzESTY) for GPCR deorphanization, helping decode their physiological roles in the brain and immune system. He also explores signaling bias, investigating how different ligands induce distinct signaling cascades through the same receptor. His recent work uncovered pivotal roles for orphan GPCRs in macrophage immune function and neuronal communication, highlighting their therapeutic potential. Collaborating across pharmacology, neuroscience, and structural biology, he integrates in vitro, in vivo, and computational methods. His lab has also contributed to understanding how GPCRs interact with psychoactive cannabinoids and prostaglandins, which has implications for pain, inflammation, and psychiatric disorders. His research is highly translational, aiming to inform next-generation drug discovery in neuropharmacology and immunomodulation.

Publications Top Notes: 

  1. 🧬 Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons – Journal of Medicinal Chemistry, 2025

  2. 🧪 Pancreatic Exocrine Signaling and Function Require Gαq Activation – The Journal of Physiology, 2025

  3. 🧫 GzESTY: An Optimized Cell-Based Assay for GPCR Deorphanization – Nature Communications, 2025

  4. 🧉 Orphan GPCR GPRC5B Controls Macrophage Function via Prostaglandin E2 Signaling – Nature Communications, 2025

  5. 🧠 Gα Protein Signaling Bias at the 5-HT1A Receptor – Molecular Pharmacology, 2023

  6. 🧠 Spatial Profile of Orphan GPCR GPRC5B Expression in Mouse Brain – Frontiers in Neuroscience, 2022

  7. 🔍 In Vitro Profiling of Orphan GPCR Constitutive Activity – British Journal of Pharmacology, 2021

  8. 🧩 Cell-Adhesion Molecules Regulate Cone Photoreceptor Synaptic Wiring – PNAS, 2020

  9. 🎮 NF1-cAMP Signaling Links Striatal Neurons to Reward and Motor Control – PLOS Biology, 2019

  10. 🚫 Genetic Behavioral Screen Identifies an Orphan Anti-Opioid System – Science, 2019

Conclusion:

Dr. Cesare Orlandi stands out as an exceptional researcher whose work has advanced the frontiers of molecular pharmacology, especially in the complex field of orphan GPCRs. His innovative methodologies, strong publication track record, and interdisciplinary collaborations make a compelling case for recognition through the Best Researcher Award. While there is room to further highlight his grant leadership and translational reach, his scientific output and leadership are already at a level that merits this award.

Weili Miao | RNA biology | Best Researcher Award

Published on by Cell Biologist

Dr. Weili Miao | RNA biology | Best Researcher Award

Dr. Weili Miao, Stanford University, United States

Dr. Weili Miao is an accomplished molecular biologist with a focus on RNA biology, biomolecule interactions, and translational control. She earned her Ph.D. in Chemistry from the University of California, Riverside, and currently serves as a postdoctoral researcher at Stanford University. Her work has uncovered novel functions of biomolecule interactions in gene expression, with implications for tissue differentiation and disease. Dr. Miao’s high-impact publications in Cell, Nature Communications, and Nucleic Acids Research reflect her technical rigor and creativity. She is a recipient of the prestigious NIH K01 Award and has developed state-of-the-art techniques like irCLIP-RNP and PROBER. Her interdisciplinary research bridges chemistry, biology, and medicine, making significant strides in understanding gene regulation mechanisms. Dr. Miao is an emerging leader in her field and continues to inspire with her meticulous research and impactful discoveries.

Publication Profile: 

Google Scholar

scopus

Strengths for the Award:

  1.  Outstanding Publication Record:
    Dr. Miao is first or co-first author on multiple high-impact publications in top-tier journals such as Cell, Nature Communications, Nature Reviews Molecular Cell Biology, and Nucleic Acids Research. These reflect cutting-edge research on RNA-protein interactions and gene regulation.

  2.  Innovative Method Development:
    She has contributed to the development and application of innovative molecular tools including easy-CLIP, irCLIP-RNP, PROBER, and MST—advancing the technical landscape for RNA/DNA-protein interaction studies.

  3.  Novel Biological Discoveries:
    Her discoveries, particularly regarding glucose’s unexpected regulatory role in RNA-binding proteins such as DDX21, DDX50, and NSUN2, have significantly advanced our understanding of metabolic-epigenetic regulation in tissue differentiation.

  4.  Prestigious Funding:
    Recipient of the NIH K01 Mentored Research Scientist Development Award (2024–2029), highlighting her potential for becoming an independent research leader.

  5.  Cross-Disciplinary Collaboration:
    Extensive collaborations across structural biology, biochemistry, and systems biology with prominent labs at Stanford, showcasing her integrative approach and strong team science credentials.

Areas for Improvement:

  1.  Global Science Communication:
    Greater involvement in public science engagement, outreach, or policy translation could expand the societal impact of her work.

  2.  Independent Research Leadership:
    While she has secured the NIH K01 award, leading a research group or mentoring postdoctoral scholars would further elevate her academic stature.

  3.  Translational Impact:
    Strengthening clinical or translational applications of her findings—particularly in cancer or metabolic disease—could increase her visibility in applied biomedical research.

Education:

Dr. Weili Miao completed her Ph.D. in Chemistry at the University of California, Riverside in May 2019, where she specialized in proteomics and biomolecular interactions. During her doctoral studies, she developed quantitative proteomic techniques to study kinase activity and m6A modifications, contributing significantly to our understanding of stress responses and cancer biology. Prior to her Ph.D., she earned her Bachelor of Science in Chemistry from the prestigious Fudan University, China, in June 2014. Her educational background blends a strong foundation in chemistry with advanced molecular biology, enabling her to approach scientific questions with precision and innovation. Her academic training has been instrumental in driving her postdoctoral research in RNA-protein interaction networks and biomolecule regulation. These formative experiences laid the groundwork for her high-impact contributions to biomedical science and continue to support her trajectory as an independent investigator.

Research Experience:

Since September 2019, Dr. Weili Miao has been a Postdoctoral Researcher at Stanford University, where she explores how biomolecules such as glucose regulate RNA- and DNA-binding proteins. Her pioneering discoveries revealed that glucose binds DDX21, DDX50, and NSUN2, influencing mRNA splicing and epidermal differentiation. She has expertly incorporated advanced methodologies like irCLIP-RNP, easy-CLIP, PROBER, and MST, contributing to a deeper understanding of RNA biology and epigenetics. Prior to this, her Ph.D. work at UC Riverside involved proteome-wide characterization of kinase activity and m6A RNA modifications in stress and cancer contexts. Her work stands out for both technical innovation and biological relevance. Dr. Miao’s interdisciplinary background in proteomics, RNA biology, and structural biochemistry positions her at the forefront of biomedical discovery. She collaborates with leaders in the field and contributes to major scientific consortia, demonstrating a trajectory of excellence and leadership in research.

Awards and Honors:

Dr. Weili Miao has received numerous prestigious honors recognizing her scientific excellence and research promise. In 2024, she was awarded the NIH K01 Mentored Research Scientist Development Award (2024–2029), affirming her potential as a future independent investigator. During her Ph.D. at UC Riverside, she earned the Dissertation Year Program Fellowship (2018–2019), recognizing her outstanding doctoral research. In 2019, she received the Award for Outstanding Self-financed Students Abroad, a highly competitive honor granted by the Chinese government to top-performing international scholars. These accolades reflect her consistent high-impact research and innovation in RNA biology, proteomics, and biomolecule interaction networks. Her ability to secure national-level funding and recognition at every stage of her career demonstrates a rare combination of technical expertise, leadership, and strategic research vision. Dr. Miao’s honors not only validate her achievements but also highlight her rising influence in the field of molecular and cellular biology.

Research Focus:

Dr. Weili Miao’s research focuses on the molecular mechanisms by which small biomolecules regulate RNA-, DNA-, and protein-binding factors, with implications for gene expression, tissue development, and disease. At Stanford, she investigates how metabolites like glucose modulate RNA-binding proteins (e.g., DDX21, NSUN2), using integrative methods such as mass spectrometry, RNA-protein crosslinking, and structural analysis. Her work has uncovered how these interactions affect mRNA splicing, RNA stability, and translation—pivotal processes in differentiation and disease progression. Dr. Miao also advances novel tools for mapping protein interactions (e.g., PROBER, irCLIP-RNP), enabling more precise interrogation of functional biomolecular networks. Her long-term goal is to unravel the interplay between metabolism and gene regulation in health and disease. Through cutting-edge research, she bridges proteomics, RNA biology, and cell signaling, delivering insights that are both mechanistically profound and clinically relevant.

Publications Top Notes:

  1.  Regulation of RNA-binding proteins by small biomolecules, Nat. Rev. Mol. Cell Biol., 2025, in press

  2.  DDX50 cooperates with STAU1 to effect stabilization of pro-differentiation RNAs, Cell Rep., 2025

  3.  Disease-Linked Regulatory DNA Variants and Homeostatic Transcription Factors in Epidermis, Nat. Commun., 2025

  4.  Glucose binds and activates NSUN2 to promote translation and epidermal differentiation, Nucleic Acids Res., 2024

  5.  Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation, Cell, 2023

  6.  Targeted Proteomic Approaches for AMP-binding Capacities of Kinases, J. Proteome Res., 2022

  7.  Roles of N6-Methyladenosine in Heat Shock Response, J. Proteome Res., 2021

  8.  Kinome Reprogramming During Radiation Resistance in Breast Cancer Cells, J. Proteome Res., 2021

  9.  SARS-CoV-2 Spike Variants Bind Human ACE2 with Increased Affinity, Lancet Infect. Dis., 2021

  10.  Kinome Reprogramming During Melanoma Metastasis, Sci. Rep., 2020

Conclusion:

Dr. Weili Miao is a highly accomplished early-career scientist whose contributions to RNA biology and biomolecule interaction networks are both profound and innovative. Her ability to integrate quantitative proteomics, molecular biology, and structural techniques positions her uniquely within the biomedical research landscape. With an exceptional record of first-author publications, advanced technical skills, and independent funding secured, Dr. Miao not only meets but exceeds the standards for the Best Researcher Award. While expanding her translational footprint and leadership responsibilities could further solidify her trajectory, she is unequivocally a top-tier candidate deserving of recognition.

Chao Wang | Animal Nutrition | Best Researcher Award

Published on by Cell Biologist

Dr. Chao Wang | Animal Nutrition | Best Researcher Award

Dr. Chao Wang, Nanjing Agricultural University, China

Dr. Wang Chao is an Associate Professor at the College of Animal Science, Nanjing Agricultural University. He specializes in environmental biology, animal physiology, and soil carbon dynamics. Over the years, Dr. Wang has made impactful contributions to sustainable agriculture through his work on soil remediation, climate-resilient farming, and animal health. He has been the principal investigator for several prestigious projects, including those funded by the National Natural Science Foundation of China. With over 20 published articles in high-impact journals, his work bridges the disciplines of plant biology, environmental science, and veterinary studies. His recent research investigates how bioactive compounds like rutin improve animal resilience to stress. He is also exploring the genomic mechanisms underpinning plant adaptation and soil methane sink capacity. Dr. Wang’s holistic approach and interdisciplinary collaborations make him a valuable contributor to global sustainability efforts.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Diverse and High-Impact Research Portfolio:
    Dr. Wang Chao has published over 20 peer-reviewed articles across a range of impactful journals including Journal of Cleaner Production, Planta, Global Change Biology, and Nutrients. His research bridges several urgent scientific themes such as climate change, animal physiology, soil remediation, and genomics.

  2. Leadership in National Research Projects:
    He has served as the principal investigator for multiple national-level projects, including the National Natural Science Foundation of China, showcasing leadership in planning, funding acquisition, and execution of complex scientific studies.

  3. Interdisciplinary Research Scope:
    His work spans environmental sustainability, livestock health, plant genomics, and soil carbon sequestration, addressing both agricultural productivity and climate resilience.

  4. Focus on Practical Solutions:
    Dr. Wang’s research addresses real-world agricultural challenges such as saline-alkali land restoration, heat stress in poultry, and soil methane reduction, all of which align with global goals like carbon neutrality and food security.

  5. Recent Publications (2025):
    His recent papers demonstrate continued engagement with frontier topics and signal research activity at a high level in the current year.

Areas for Improvement:

  1. Citation Impact and Global Recognition:
    While his research is timely, most recent papers have 0 or 1 citation, likely due to their recency. Strategic dissemination through conferences, invited talks, and policy briefs could enhance reach and impact.

  2. International Collaborations and Patents:
    While national recognition is evident, more international joint publications or technology transfer (e.g., patents, industry partnerships) could elevate the global relevance of his work.

  3. Author Position Clarity:
    Author roles (first, last, corresponding) are not fully visible from the summary. Greater visibility as lead or senior author could strengthen his research leadership profile.

Education:

Dr. Wang Chao holds advanced degrees in Agricultural and Environmental Sciences. He earned his Ph.D. in Animal Science from Nanjing Agricultural University, focusing on biochemical and molecular responses to environmental stress in livestock. Prior to his doctorate, he completed his Master’s degree in Veterinary Medicine, where he explored nutrient metabolism and antioxidant mechanisms in poultry. His academic foundation was laid with a Bachelor’s degree in Animal Husbandry, equipping him with a broad understanding of animal genetics, physiology, and health. Throughout his academic career, Dr. Wang consistently demonstrated excellence, earning scholarships and research distinctions. He also undertook postdoctoral training in environmental sustainability and genomic biology, expanding his expertise into plant-soil interactions and climate-related impacts on agriculture. His diverse and rigorous academic background has enabled him to lead multidisciplinary research initiatives and mentor the next generation of scientists.

Experience:

Dr. Wang Chao currently serves as an Associate Professor at the College of Animal Science, Nanjing Agricultural University. Over his academic career, he has led and collaborated on numerous national-level projects, especially those funded by the National Natural Science Foundation of China. His teaching experience spans undergraduate and postgraduate levels, focusing on animal physiology, environmental toxicology, and sustainable agricultural systems. He has supervised numerous graduate theses and serves on several academic review boards. Dr. Wang also collaborates with researchers across environmental, biological, and agricultural sciences, contributing to multi-institutional studies on climate change and food security. His administrative duties include curriculum development, faculty coordination, and international research exchange programs. His experience reflects a balance of academic leadership, field research, and laboratory innovation, making him a well-rounded academic and a leading voice in eco-agriculture and animal health research.

Research Focus:

Dr. Wang Chao’s research centers around sustainable agriculture, animal environmental physiology, and soil-plant interactions. He investigates how abiotic stressors like heat and soil salinity impact animal metabolism and soil health. His work often focuses on natural compounds such as rutin and Lycium barbarum flavonoids, assessing their potential to mitigate oxidative stress and improve immune responses in livestock. In parallel, Dr. Wang explores carbon sequestration and soil multifunctionality in degraded and saline-alkali lands, helping to restore ecosystem services. His research also includes transposable elements in plant genomes, contributing to genetic resilience in crops. He combines fieldwork with molecular biology techniques, offering solutions for climate adaptation in agriculture. His studies on methane sink capacity of soils align with global carbon-neutral goals. Altogether, his research is distinguished by its interdisciplinary reach, real-world relevance, and focus on environmental sustainability.

Publications Top Notes:

  1.  Location-optimized remediation measures for soil multifunctionality and carbon sequestration of saline-alkali land in China – Journal of Cleaner Production

  2.  Genome-wide annotation and comparative analysis of miniature inverted-repeat transposable elements (MITEs) in six pear species – Planta

  3.  Rutin alleviates heat stress induced hepatic abnormal lipid metabolism of broilers via improving antioxidant capacity to maintain mitochondrial homeostasis – Journal of Thermal Biology

  4.  Generally Reduced Sink Capacity of Upland Soils for Atmospheric Methane Over the Past Three Decades (1993–2022) – Global Change Biology

  5.  Dietary Rutin Ameliorates Nanoparticle Zinc Oxide-Induced Toxicity in Mice by Potentiating Antioxidant Defense Mechanisms – Nutrients

  6.  Effects of Different Levels of Lycium barbarum Flavonoids on Growth Performance, Immunity, Intestinal Barrier and Antioxidant Capacity of Meat Ducks – Antioxidants

Conclusion:

Dr. Wang Chao is well-qualified and highly suitable for the Best Researcher Award based on the breadth, relevance, and scientific rigor of his work. His leadership in national projects, focus on sustainability and animal welfare, and consistent scholarly output in 2025 position him as a forward-thinking and impactful researcher. With growing international visibility and long-term citation impact, he has strong potential to emerge as a global leader in sustainable agricultural science.